Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

Completed

Conditions studied: Medication Non-Adherence

In brief

Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the seriousness of the disease, and fear of side effects. An intervention strategy comprising 3-5 minutes of counseling, emotional support and cost-sharing may be motivational and improve adherence to treatment.

Key facts

Study ID

NCT01078285

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

500

Starts

2010-03-01

Expected to finish

2011-11-01

Last updated by the study team

2021-02-18

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male and female aged >21 years
• Have received a new or re-fil prescription for atorvastatin at first study visit to Prairie Heart Institute
• Signed informed consent

You may not qualify if…

• Unwilling to give written informed consent
• Failed statin treatment in the past
• Switched from another statin to atorvastatin because of co-pay program
• Participated in an earlier Market Research study on Impact of cholesterol management behaviors post in-clinic adherence intervention

Where it is running

• Prairie Heart Institute — Springfield, Illinois, United States
• Memorial Medical Center — Springfield, Illinois, United States
• Prairie Diagnostic Center — Springfield, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.